focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,166.00
Bid: 11,500.00
Ask: 12,200.00
Change: 0.00 (0.00%)
Spread: 700.00 (6.087%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,166.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

CORRECTED-Hundreds queue up as Latvia offers walk-in AstraZeneca shots

Fri, 16th Apr 2021 11:30

(Corrects spelling of Riga resident Kovalevs' name in 4th
paragraph)

By Janis Laizans and Andrius Sytas

RIGA, April 16 (Reuters) - People in their 30s showed up in
their hundreds on Friday morning as Latvia offered the
AstraZeneca vaccine to anyone who wanted it in order to
clear a growing backlog of the shot often refused by the old.

Latvia is now vaccinating people over 65 and those with
chronic illnesses, but many do not show up when told they will
be given AstraZeneca.

Denmark this week became the first country to stop using
AstraZeneca altogether, as European officials investigate
reports of rare blood clots. Many countries have resumed using
the shot, with some restricting it to certain age groups, mostly
those aged above 50 or above 60.

“We queued two and half hours before opening, around 6:30 in
the morning, because this is the only way out of this for us,”
Riga resident Vladlens Kovalevs told Reuters at a converted
convention centre in the city.

Partly due to hesitancy over AstraZeneca, Latvia has been
lagging in vaccination, with only 7.8% of adults getting at
least a single dose by Sunday, the worst result in the European
Union, according to European Centre for Disease Control and
Prevention.

A total of about 8,000 doses were distributed to seven
vaccination centres around the country, to be used over the
weekend, in one of the first open-to-all COVID-19 vaccination
schemes in the EU.

"We had an AstraZeneca surplus and to avoid keeping vaccines
in the warehouse we decided to make this walk-in line open to
anyone", said the chief of Latvia's vaccination programme, Eva
Juhnevica.

Latvia and neighbouring Lithuania asked Denmark to sell them
its leftover vaccines to speed up their own efforts.

In the Lithuanian capital Vilnius, a similar backlog of
vaccines was cleared after being offered to the young, who were
not expecting to get a shot so early.

"People over 65 in Vilnius are extremely reluctant to take
AstraZeneca vaccine - so we began giving them Pfizer vaccine,
and opened up AstraZeneca vaccination to priority groups
containing younger people", Vilnius mayor Remigijus Simasius
told Reuters. "And the vaccination is now going smoothly."
(Reporting by Janis Laizans in Riga and Andrius Sytas in
Vilnius
Writing by Andrius Sytas
Editing by Giles Elgood)

More News
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.